Xuelin (Steve) Wang
Lawyers
Filters
Laekna Therapeutics $61 million Series D financing
We are advising Laekna Therapeutics in connection with its Series D financing
Zhenro Properties exchange offer and consent solicitations
The consent solicitations involve notes and perpetual securities
Yonghe HK$1.49 billion IPO
The shares are listed on the HKEX
CANbridge Pharmaceuticals HK$685 million IPO
We advised CANbridge Pharmaceuticals on its IPO and HKEX listing
MicroTech Medical HK$1.82 billion IPO
We advised MicroTech Medical on its IPO and HKEX listing
Abbisko HK$1.7 billion IPO
We advised Abbisko on its IPO and HKEX listing
Broncus Holding HK$1.55 billion IPO
We advised Broncus on its IPO and HKEX listing
Kindstar Globalgene Technology HK$2.21 billion IPO
We advised Kindstar Global on its IPO and HKEX listing
Zhenro Properties Group RMB1.3 billion green high-yield notes offering
We advised the initial purchasers on the Regulation S offering of senior notes, issued under Zhenro’s green bond framework
Zylox-Tonbridge Medical Technology HK$2.56 billion IPO
We advised Zylox-Tonbridge Medical Technology on its IPO and HKEX listing